Q: Is 360 High-Risk Vulnerability Immunization Tool V2.0 a good alternative to Titania?

360 High-Risk Vulnerability Immunization Tool V2.0 and Titania serve similar Vulnerability Assessment use cases: both are Vulnerability Assessment tools. Review the feature comparison above to determine which fits your requirements.

Question 1

What is the difference between 360 High-Risk Vulnerability Immunization Tool V2.0 vs Titania?

Accepted Answer

**360 High-Risk Vulnerability Immunization Tool V2.0**: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). headquartered in China. Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

**Titania**: Network device vulnerability assessment and config compliance platform. built by Titania. headquartered in United Kingdom. Core capabilities include Network device vulnerability assessment, Real-time network change visibility and analysis, Configuration drift monitoring..

Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.

Question 2

What features do 360 High-Risk Vulnerability Immunization Tool V2.0 vs Titania offer?

Accepted Answer

**360 High-Risk Vulnerability Immunization Tool V2.0** differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. **Titania** differentiates with Network device vulnerability assessment, Real-time network change visibility and analysis, Configuration drift monitoring.

Question 3

Who makes 360 High-Risk Vulnerability Immunization Tool V2.0 vs Titania?

Accepted Answer

**360 High-Risk Vulnerability Immunization Tool V2.0** is developed by 360 Security Group (Qihoo 360). **Titania** is developed by Titania. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.